OPCH Pengajuan SEC - Option Care Health, Inc.- Laporan Tahunan, Pernyataan Kuasa, Prospektus

Mga Batayang Estadistika

LEI	549300DI3Q5ACSYJRI17
CIK	1014739

SEC Filings

All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Option Care Health, Inc.

SEC Filings (Chronological Order)

Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.

August 20, 2025	EX-99.1	Option Care Health Announces Chief Financial Officer Transition Mike Shapiro to Step Down After 10 Years With the Company; Meenal Sethna Named EVP and CFO Effective October 1, 2025 Exhibit 99.1 Option Care Health Announces Chief Financial Officer Transition Mike Shapiro to Step Down After 10 Years With the Company; Meenal Sethna Named EVP and CFO Effective October 1, 2025 BANNOCKBURN, Ill., August 20, 2025 – Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services,
August 20, 2025	EX-10.2	TRANSITION AGREEMENT AND RELEASE Exhibit 10.2 TRANSITION AGREEMENT AND RELEASE This agreement (“Agreement”) is entered into between Michael Shapiro (“Employee”) and Option Care Enterprises, Inc. (“Option Care”). 1.              Transition and Separation from Employment. (a)            Transition and Separation from Employment. Effective as of October 1, 2025 (“Transition Date”), Employee shall step down from Employee’s position a
August 20, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 19, 2025 OPTION CARE HEALTH UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 19, 2025 OPTION CARE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-11993 05-0489664 (State or other jurisdiction of incorporation) (Commission
August 20, 2025	EX-10.1	Mike Bavaro Exhibit 10.1 Mike Bavaro Chief Human Resources Officer August 19, 2025 Meenal Sethna [Redacted] Cc: John Rademacher - CEO Dear Meenal, We are pleased to offer you the position of Chief Financial Officer at Option Care Health, Inc. (the "Company") reporting to the Company’s Chief Executive Officer. In the CFO role, you will be an Executive Officer of the Company. Your anticipated start date is Octo
July 30, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 30, 2025 OPTION CARE HEALTH, UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 30, 2025 OPTION CARE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-11993 05-0489664 (State or other jurisdiction of incorporation) (Commission F
July 30, 2025	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-11993 OPTION CAR
July 30, 2025	EX-99.1	OPTION CARE HEALTH ANNOUNCES FINANCIAL RESULTS FOR THE SECOND QUARTER ENDED JUNE 30, 2025 Exhibit 99.1 OPTION CARE HEALTH ANNOUNCES FINANCIAL RESULTS FOR THE SECOND QUARTER ENDED JUNE 30, 2025 BANNOCKBURN, IL., July 30, 2025 - Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today financial results for the second quarter ended June 30, 2025. Second Quarter 2
May 16, 2025	EX-3.2	Amended and Restated By-Laws of Option Care Health, Inc., effective as of May 14, 2025 (incorporated by reference to Exhibit 3.2 to the Company's Current Report on Form 8-K filed on May 16, 2025). Exhibit 3.2 AMENDED AND RESTATED BY-LAWS of OPTION CARE HEALTH, INC. (A Delaware Corporation) ARTICLE 1 Offices Section 1.1.Offices. The Corporation may have offices at such places both within and without the State of Delaware as the Board of Directors may from time to time determine or the business of the Corporation may require. ARTICLE 2 Meetings of Stockholders Section 2.1.Place of Meeting. Me
May 16, 2025	EX-3.1	Fourth Amended and Restated Certificate of Incorporation of Option Care Health, Inc. effective as of May 14, 2025. Exhibit 3.1 FOURTH AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF OPTION CARE HEALTH, INC. * * * * * Option Care Health, Inc., a corporation duly organized and existing under and by virtue of the General Corporation Law of the State of Delaware (the “Corporation”), DOES HEREBY CERTIFY as follows: FIRST: The name of the Corporation is Option Care Health, Inc. The Corporation’s original Certif
May 16, 2025	8-K	Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 14, 2025 OPTION CARE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-11993 05-0489664 (State or other jurisdiction of incorporation) (Commission Fi
April 29, 2025	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-11993 OPTION CA
April 29, 2025	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 29, 2025 OPTION CARE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-11993 05-0489664 (State or other jurisdiction of incorporation) (Commission
April 29, 2025	EX-99.1	OPTION CARE HEALTH ANNOUNCES FINANCIAL RESULTS FOR THE FIRST QUARTER ENDED MARCH 31, 2025 Exhibit 99.1 OPTION CARE HEALTH ANNOUNCES FINANCIAL RESULTS FOR THE FIRST QUARTER ENDED MARCH 31, 2025 BANNOCKBURN, IL., April 29, 2025 - Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today financial results for the first quarter ended March 31, 2025. First Quarter 2
April 2, 2025	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.
April 2, 2025	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.
March 19, 2025	PRE 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.
February 26, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 26, 2025 OPTION CARE HEAL UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 26, 2025 OPTION CARE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-11993 05-0489664 (State or other jurisdiction of incorporation) (Commissi
February 26, 2025	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-11993 OPTION CARE HE
February 26, 2025	EX-99.1	OPTION CARE HEALTH REPORTS FINANCIAL RESULTS FOR FOURTH QUARTER AND FULL YEAR 2024 Exhibit 99.1 OPTION CARE HEALTH REPORTS FINANCIAL RESULTS FOR FOURTH QUARTER AND FULL YEAR 2024 BANNOCKBURN, IL., February 26, 2025 - Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today financial results for the fourth quarter and full year ended December 31, 2024. F
February 26, 2025	EX-19	Insider Trading Policy (filed herewith). Insider Trading Policy (Effective December 13, 2024) PURPOSE: Federal and state securities laws prohibit individuals from trading in the securities of a company while they are aware of material information about that company that is not generally known or available to the public.
February 26, 2025	EX-21.1	List of subsidiaries of Option Care Health, Inc. (filed herewith). EXHIBIT 21.1 OPTION CARE HEALTH, INC. AND ITS SUBSIDIARIES Entity Name State of Incorporation Doing Business As BioScrip Infusion Services, Inc. California BioScrip Infusion Services BioScrip Infusion Services, LLC Delaware BioScrip Infusion Services BioScrip PBM Services, LLC Delaware BioScrip PBM Services BioScrip Pharmacy Services, Inc. Ohio BioScrip Pharmacy Services CHI Holding Corporation De
January 13, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 10, 2025 OPTION CARE HEALT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 10, 2025 OPTION CARE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-11993 05-0489664 (State or other jurisdiction of incorporation) (Commissio
January 13, 2025	EX-99.2	© 2025 OPTION CARE HEALTH, INC. ALL RIGHTS RESERVED EXTRAORDINARY CARE THAT CHANGES LIVES January 2025 J.P. MORGAN HEALTHCARE CONFERENCE 1 Exhibit 99.2 © 2025 OPTION CARE HEALTH, INC. ALL RIGHTS RESERVED EXTRAORDINARY CARE THAT CHANGES LIVES January 2025 J.P. MORGAN HEALTHCARE CONFERENCE 1 © 2025 OPTION CARE HEALTH, INC. ALL RIGHTS RESERVED Disclaimers Forward - Looking Statements This presentation may contain “forward - looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Ref
January 13, 2025	EX-99.1	OPTION CARE HEALTH ANNOUNCES PRELIMINARY FINANCIAL RESULTS FOR FOURTH QUARTER AND FULL YEAR 2024 AND PRELIMINARY FINANCIAL EXPECTATIONS FOR FULL YEAR 2025 Exhibit 99.1 OPTION CARE HEALTH ANNOUNCES PRELIMINARY FINANCIAL RESULTS FOR FOURTH QUARTER AND FULL YEAR 2024 AND PRELIMINARY FINANCIAL EXPECTATIONS FOR FULL YEAR 2025 BANNOCKBURN, IL., January 13, 2025 - Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today preliminar
December 4, 2024	EX-99	JOINT FILING AGREEMENT JOINT FILING AGREEMENT The undersigned hereby agree that this Schedule 13G (the “Schedule 13G”) with respect to the common stock of Option Care Health, Inc.
November 8, 2024	EX-99	JOINT FILING AGREEMENT JOINT FILING AGREEMENT The undersigned hereby agree that this Schedule 13G (the “Schedule 13G”) with respect to the common stock of Option Care Health, Inc.
November 8, 2024	SC 13G	OPCH / Option Care Health, Inc. / WELLINGTON MANAGEMENT GROUP LLP - SEC SCHEDULE 13G Passive Investment SC 13G 1 SEC13GFiling.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Option Care Health, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 68404L201 (CUSIP Number) September 30, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate box
October 30, 2024	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) October 30, 2024 OPTION CARE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-11993 05-0489664 (State or other jurisdiction of incorporation) (Commissio
October 30, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-11993 OPTIO
October 30, 2024	EX-99.1	OPTION CARE HEALTH ANNOUNCES FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2024 Exhibit 99.1 OPTION CARE HEALTH ANNOUNCES FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2024 BANNOCKBURN, IL., October 30, 2024 - Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today financial results for the third quarter ended September 30, 2024. Third
September 6, 2024	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) September 3, 2024 OPTION CARE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-11993 05-0489664 (State or other jurisdiction of incorporation) (Commissi
September 6, 2024	EX-3.1	Fifth Amended and Restated By-Laws of Option Care Health, Inc., effective as of September FOURTH AMENDED AND RESTATED BY-LAWS of OPTION CARE HEALTH, INC. (A Delaware Corporation) Article 1 Offices Section 1.1.Offices. The Corporation may have offices at such places both within and without the State of Delaware as the Board of Directors may from time to time determine or the business of the Corporation may require. Article 2 Meetings of Stockholders Section 2.1.Place of Meeting. Meeting
July 31, 2024	EX-FILING FEES	Filing Fee Table. Calculation of Filing Fee Tables S-8 Option Care Health, Inc. Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee 1 Equity Common Stock, par value $0.0001 per share 457(a) 4,000,000 $ 31.23 $ 124,920,000.00 0.0001476 $ 18,438.19 To
July 31, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-11993 OPTION CAR
July 31, 2024	S-8	As filed with the Securities and Exchange Commission on July 31, 2024 As filed with the Securities and Exchange Commission on July 31, 2024 Registration No.
July 31, 2024	EX-99.1	OPTION CARE HEALTH ANNOUNCES FINANCIAL RESULTS FOR THE SECOND QUARTER ENDED JUNE 30, 2024 Exhibit 99.1 OPTION CARE HEALTH ANNOUNCES FINANCIAL RESULTS FOR THE SECOND QUARTER ENDED JUNE 30, 2024 BANNOCKBURN, IL., July 31, 2024 - Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today financial results for the second quarter ended June 30, 2024. Second Quarter 2
July 31, 2024	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 31, 2024 OPTION CARE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-11993 05-0489664 (State or other jurisdiction of incorporation) (Commission F
May 17, 2024	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 15, 2024 OPTION CARE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-11993 05-0489664 (State or other jurisdiction of incorporation) (Commission Fi
May 10, 2024	EX-10.1	Third Amendment to Amended and Restated First Lien Credit Agreement, dated as of May 8, 2024, among Option Care Health, Inc. (f/k/a BioScrip, Inc.), a Delaware corporation, each other Loan Party (as defined in therein) party thereto, each Existing Term Lender (as defined therein) party thereto, the Replacement Lender (as defined therein), the 2024 Incremental Term Lender (as defined therein) and Bank of America, N.A. (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on May 10, 2024). Exhibit 10.1 THIRD AMENDMENT TO AMENDED AND RESTATED FIRST LIEN CREDIT AGREEMENT This THIRD AMENDMENT TO AMENDED AND RESTATED FIRST LIEN CREDIT AGREEMENT, dated as of May 8, 2024 (this “Amendment”), among Option Care Health, Inc. (f/k/a BioScrip, Inc.), a Delaware corporation (the “Parent Borrower” and a “Borrower”), each other Loan Party party hereto, each Existing Term Lender (as defined below),
May 10, 2024	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 8, 2024 OPTION CARE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-11993 05-0489664 (State or other jurisdiction of incorporation) (Commission Fil
April 23, 2024	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 23, 2024 OPTION CARE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-11993 05-0489664 (State or other jurisdiction of incorporation) (Commission
April 23, 2024	EX-99.1	OPTION CARE HEALTH ANNOUNCES FINANCIAL RESULTS FOR THE FIRST QUARTER ENDED MARCH 31, 2024 Exhibit 99.1 OPTION CARE HEALTH ANNOUNCES FINANCIAL RESULTS FOR THE FIRST QUARTER ENDED MARCH 31, 2024 BANNOCKBURN, IL., April 23, 2024 - Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today financial results for the first quarter ended March 31, 2024. First Quarter 2
April 23, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-11993 OPTION CA
April 23, 2024	EX-10.2	Form of Option Care Health, Inc. Restricted Stock Unit Certificate (Executive) (filed herewith). OPTION CARE HEALTH, INC. RESTRICTED STOCK UNIT CERTIFICATE THIS RESTRICTED STOCK UNIT CERTIFICATE (this “Certificate”) evidences the grant by Option Care Health, Inc., a Delaware corporation (the “Company”) of Restricted Stock Units of the Company to [] (“Awardee”) on [] (the “Grant Date”) as follows: WHEREAS, the Company has established the Option Care Health, Inc. Amended and Restated 2018 Equit
April 23, 2024	EX-10.3	Form of Option Care Health, Inc. Performance Stock Unit Certificate (Executive) (filed herewith). OPTION CARE HEALTH, INC. PERFORMANCE STOCK UNIT CERTIFICATE THIS PERFORMANCE STOCK UNIT CERTIFICATE (this “Certificate”) evidences the grant by Option Care Health, Inc., a Delaware corporation (the “Company”) of Performance Stock Units of the Company to [] (“Awardee”) on [] (the “Grant Date”) as follows: WHEREAS, the Company has established the Option Care Health, Inc. Amended and Restated 2018 Eq
April 23, 2024	EX-10.1	Form of Option Care Health, Inc. Non-Qualified Stock Option Certificate (Executive) (filed herewith). OPTION CARE HEALTH, INC. NON-QUALIFIED STOCK OPTION CERTIFICATE THIS NON-QUALIFIED STOCK OPTION CERTIFICATE (this “Option Certificate”) is made as of [] (the “Grant Date”) between Option Care Health, Inc., a Delaware corporation (the “Company”), and [] (the “Awardee”). WHEREAS, the Company has established the Option Care Health, Inc. Amended and Restated 2018 Equity Incentive Plan (as amended and
April 23, 2024	EX-10.4	Form of Option Care Health, Inc. Restricted Stock Unit Certificate (Directors) (filed herewith). OPTION CARE HEALTH, INC. RESTRICTED STOCK UNIT CERTIFICATE THIS RESTRICTED STOCK UNIT CERTIFICATE (this “Certificate”) evidences the grant by Option Care Health, Inc., a Delaware corporation (the “Company”) of Restricted Stock Units of the Company to [] (the “Participant”) on [] (the “Grant Date”) as follows: WHEREAS, the Company has established the Option Care Health, Inc. Amended and Restated 20
April 3, 2024	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.
April 3, 2024	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.
March 14, 2024	8-K	Regulation FD Disclosure UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) March 14, 2024 OPTION CARE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-11993 05-0489664 (State or other jurisdiction of incorporation) (Commission
February 22, 2024	EX-21.1	List of subsidiaries of Option Care Health, Inc. (filed herewith). EXHIBIT 21.1 OPTION CARE HEALTH, INC. AND ITS SUBSIDIARIES Entity Name State of Incorporation Doing Business As BioScrip Infusion Services, Inc. California Option Care Health BioScrip Infusion Services, LLC Delaware Option Care Health BioScrip PBM Services, LLC Delaware Option Care Health BioScrip Pharmacy Services, Inc. Ohio Option Care Health CHI Holding Corporation Delaware Option Care Health C
February 22, 2024	EX-10.16	Form of Letter Agreement with John C. Rademacher and Michael Shapiro Terminating Severance Provisions of Employment Agreements (filed herewith). February 21, 2024 Dear [John][Michael], As you are aware, on December 6, 2023, Option Care Health, Inc.
February 22, 2024	EX-97	Required Executive Compensation Recovery Policy, dated as of September 7, 2023, filed herewithin. OPTION CARE HEALTH, INC. REQUIRED EXECUTIVE COMPENSATION RECOVERY POLICY Adopted September 7, 2023 Policy The Board of Directors (the “Board”) of Option Care Health, Inc., a Delaware corporation (the “Company”) has adopted this Required Executive Compensation Recovery Policy (this “Policy”) pursuant to Rule 10D-1 of the Securities and Exchange Act of 1934, as amended (the “Exchange Act”), the Secu
February 22, 2024	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-11993 OPTION CARE HE
February 22, 2024	EX-99.1	OPTION CARE HEALTH REPORTS FINANCIAL RESULTS FOR FOURTH QUARTER AND FULL YEAR 2023 Exhibit 99.1 OPTION CARE HEALTH REPORTS FINANCIAL RESULTS FOR FOURTH QUARTER AND FULL YEAR 2023 BANNOCKBURN, IL., February 22, 2024 - Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today financial results for the fourth quarter and full year ended December 31, 2023. F
February 22, 2024	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 22, 2024 OPTION CARE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-11993 05-0489664 (State or other jurisdiction of incorporation) (Commissi
February 13, 2024	SC 13G/A	OPCH / Option Care Health, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SC 13G/A 1 tv01622-optioncarehealthinc.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 3)* Name of issuer: Option Care Health Inc Title of Class of Securities: Common Stock CUSIP Number: 68404L201 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the appropriate box to d
December 29, 2023	EX-10.1	Transition and Separation Agreement and Release, dated December 29, 2023, between Richard Denness and Option Care Enterprises, Inc. Exhibit 10.1 TRANSITION AND SEPARATION AGREEMENT AND RELEASE This agreement (“Agreement”) is entered into between Rich Denness (“Employee”) and Option Care Enterprises, Inc. (“Option Care”). 1.            Transition and Separation from Employment. Effective as of December 7, 2023 (“Transition Date”) and subject to Section 2 below, Employee shall step down from Employee’s position as Chief Commerci
December 29, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) December 22, 2023 OPTION CARE HEAL UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) December 22, 2023 OPTION CARE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-11993 05-0489664 (State or other jurisdiction of incorporation) (Commissi
December 11, 2023	EX-10.2	Option Care Health, Inc. Amended and Restated Executive Severance Plan Exhibit 10.2 OPTION CARE HEALTH, INC. AMENDED AND RESTATED EXECUTIVE SEVERANCE PLAN 1.              Purpose. Option Care Health, Inc., a Delaware corporation (the “Company”) considers it essential to the best interests of its stockholders to foster the continuous employment of key management personnel. The Board of Directors of the Company (the “Board”) recognizes, however, that, as is the case wi
December 11, 2023	EX-10.1	Second Amendment to Amended and Restated First Lien Credit Agreement, dated as of December 7, 2023, among Option Care Health, Inc. (f/k/a BioScrip, Inc.), a Delaware corporation, each other Loan Party (as defined therein) party thereto, each Incremental Revolving Lender Exhibit 10.1 Execution Version Annex A AMENDED AND RESTATED FIRST LIEN CREDIT AGREEMENT Dated as of October 27, 2021, as amended as of June 8, 2023, as amended as of December 7, 2023 Among OPTION CARE HEALTH, INC., as the Parent Borrower, THE GUARANTORS PARTY HERETO FROM TIME TO TIME, BANK OF AMERICA, N.A., as Administrative Agent and Swing Line Lender, THE LENDERS AND ISSUING BANKS PARTY HERETO F
December 11, 2023	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) December 6, 2023 OPTION CARE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-11993 05-0489664 (State or other jurisdiction of incorporation) (Commissio
December 11, 2023	EX-10.3	Option Care Health, Inc. Deferred Compensation Plan Exhibit 10.3 Option Care Health, Inc. Deferred Compensation Plan Effective Date December 6, 2023 Option Care Health, Inc. Deferred Compensation Plan Article I Establishment and Purpose 1 Article II Definitions 1 Article III Eligibility and Participation 5 Article IV Deferrals 6 Article V Company Contributions 9 Article VI Payments from Accounts 10 Article VII Valuation of Account Balances; Investm
December 11, 2023	EX-3.1	Fifth Amended and Restated By-Laws of Option Care Health, Inc., effective as of September 5, 2024 (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed on September 6, 2024). Exhibit 3.1 FOURTH AMENDED AND RESTATED BY-LAWS of OPTION CARE HEALTH, INC. (A Delaware Corporation) ARTICLE 1 Offices Section 1.1.            Offices. The Corporation may have offices at such places both within and without the State of Delaware as the Board of Directors may from time to time determine or the business of the Corporation may require. ARTICLE 2 Meetings of Stockholders Section 2.1.
October 25, 2023	EX-99.1	OPTION CARE HEALTH ANNOUNCES FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2023 Exhibit 99.1 OPTION CARE HEALTH ANNOUNCES FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2023 BANNOCKBURN, IL., October 25, 2023 - Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today financial results for the third quarter ended September 30, 2023. Third
October 25, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-11993 OPTIO
October 25, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) October 25, 2023 OPTION CARE HEALT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) October 25, 2023 OPTION CARE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-11993 05-0489664 (State or other jurisdiction of incorporation) (Commissio
September 11, 2023	SC 13G/A	OPCH / Option Care Health Inc. - Registered Shares / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 2)* Name of issuer: Option Care Health Inc. Title of Class of Securities: Common Stock CUSIP Number: 68404L201 Date of Event Which Requires Filing of this Statement: August 31, 2023 Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
July 27, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 27, 2023 OPTION CARE HEALTH, UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 27, 2023 OPTION CARE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-11993 05-0489664 (State or other jurisdiction of incorporation) (Commission F
July 27, 2023	EX-99.1	OPTION CARE HEALTH ANNOUNCES FINANCIAL RESULTS FOR THE SECOND QUARTER ENDED JUNE 30, 2023 Exhibit 99.1 OPTION CARE HEALTH ANNOUNCES FINANCIAL RESULTS FOR THE SECOND QUARTER ENDED JUNE 30, 2023 BANNOCKBURN, IL., July 27, 2023 - Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today financial results for the second quarter ended June 30, 2023. Second Quarter 2
July 27, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-11993 OPTION CAR
July 27, 2023	EX-10.2	First Amendment to Amended and Restated First Lien Credit Agreement, dated as of June 8, 2023, is entered into by Bank of America, N.A., as administrative agent. Exhibit 10.2 Execution Version FIRST AMENDMENT TO AMENDED AND RESTATED FIRST LIEN CREDIT AGREEMENT This FIRST AMENDMENT TO AMENDED AND RESTATED FIRST LIEN CREDIT AGREEMENT (this “Amendment”), dated as of June 8, 2023, is entered into by BANK OF AMERICA, N.A., as administrative agent (the “Administrative Agent”). Capitalized terms used herein without definition shall have the same meanings herein a
June 26, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 26, 2023 OPTION CARE HEALTH, UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 26, 2023 OPTION CARE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-11993 05-0489664 (State or other jurisdiction of incorporation) (Commission
June 26, 2023	RW	OPTION CARE HEALTH, INC. 3000 Lakeside Dr., Suite 300N Bannockburn, Illinois 60015 OPTION CARE HEALTH, INC. 3000 Lakeside Dr., Suite 300N Bannockburn, Illinois 60015 June 26, 2023 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Jessica Ansart Re: Option Care Health, Inc. Request for Withdrawal of Registration Statement on Form S-4 File No. 333-272405 Ladies and Gentlemen: In accordance with Rule 47
June 26, 2023	EX-2.1	Mutual Termination Agreement, dated as of June 26, 2023, by and among Option Care Health, Inc., Uintah Merger Sub, Inc., and Amedisys, Inc. Exhibit 2.1 Execution Version TERMINATION AGREEMENT This TERMINATION AGREEMENT (this “Agreement”), dated as of June 26, 2023, is made and entered into by and between Option Care Health, Inc., a Delaware corporation (“OPCH”), Uintah Merger Sub, Inc., a wholly owned subsidiary of OPCH and a Delaware corporation (“OPCH Merger Sub”), and Amedisys, Inc., a Delaware corporation (“Amedisys”, together wit
June 26, 2023	EX-99.1	Option Care Health Confirms Termination of Merger Agreement with Amedisys Highlights Strength of Platform and Track Record of Execution and Value Creation Exhibit 99.1 Option Care Health Confirms Termination of Merger Agreement with Amedisys Highlights Strength of Platform and Track Record of Execution and Value Creation BANNOCKBURN, Ill., June 26, 2023 - Option Care Health, Inc. (“Option Care Health” or the “Company”) (Nasdaq: OPCH) today announced that it has terminated its previously announced agreement to combine with Amedisys, Inc. (“Amedisys”)
June 21, 2023	8-K	Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 16, 2023 OPTION CARE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-11993 05-0489664 (State or other jurisdiction of incorporation) (Commission
June 21, 2023	425	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 16, 2023 OPTION CARE HEALTH, UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 16, 2023 OPTION CARE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-11993 (Commission File Number
June 12, 2023	SC 13D/A	OPCH / Option Care Health Inc. - Registered Shares / Walgreens Boots Alliance, Inc. - SC 13D/A Activist Investment SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 3)* Option Care Health, Inc. (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securities) 68404L201 (CUSIP Number) Danielle C. Gray Executive Vice President, Global Chief Legal Officer Walgreens Boots Alliance, Inc. 108 Wilmot R
June 5, 2023	EX-FILING FEES	Filing Fee Table. Exhibit 107 Calculation of Filing Fee Tables Form S-4 (Form Type) Option Care Health, Inc.
June 5, 2023	EX-99.1	Consent of Goldman Sachs & Co. LLC. Exhibit 99.1 200 West Street \| New York, NY 10282-2198 Tel: 212-902-1000 \| Fax: 212-902-3000 June 5, 2023 Board of Directors Option Care Health, Inc. 3000 Lakeside Drive, Suite 300N Bannockburn, IL 60015 Re: Registration Statement on Form S-4 of Option Care Health, Inc., filed June 5, 2023 (the “Registration Statement”) Ladies and Gentlemen: Reference is made to our opinion letter, dated May 3, 20
June 5, 2023	S-4	As filed with the Securities and Exchange Commission on June 5, 2023 TABLE OF CONTENTS As filed with the Securities and Exchange Commission on June 5, 2023 No.
June 5, 2023	EX-99.2	Consent of Guggenheim Securities, LLC. Exhibit 99.2 Guggenheim Securities, LLC 330 Madison Avenue New York, New York 10017 GuggenheimPartners.com June 5, 2023 The Board of Directors Amedisys, Inc. 3854 American Way, Suite A Baton Rouge, LA 70816 Re: Consent for Fairness Opinion Disclosure Members of the Board: Guggenheim Securities, LLC (“Guggenheim Securities”) hereby consents to (i) the inclusion of our opinion letter dated May 3, 20
May 26, 2023	425	Filed by Option Care Health, Inc. Filed by Option Care Health, Inc. Pursuant to Rule 425 of the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934 Subject Company: Amedisys, Inc. Commission File No.: 000-24260 Explanatory Note: The following is a screenshot of an updated web page on the website hosted at www.optioncarehealthamedisys.com in connection with the proposed merger of O
May 19, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 17, 2023 OPTION CARE HEALTH, I UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 17, 2023 OPTION CARE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-11993 05-0489664 (State or other jurisdiction of incorporation) (Commission Fi
May 17, 2023	425	Filed by Option Care Health, Inc. Filed by Option Care Health, Inc. Pursuant to Rule 425 of the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934 Subject Company: Amedisys, Inc. Commission File No.: 000-24260 Explanatory Note: The following is an excerpt from Option Care Health Inc.’s webcast of its 2023 annual meeting held on May 17, 2023: Our Q1 2023 results continue to demons
May 15, 2023	425	Investor Presentation May 15, 2023 + + Disclaimer 2 No Offer or Solicitation This communication relates to the proposed merger (the “proposed transaction”) between Option Care Health, Inc. (“Option Care Health”) and Amedisys, Inc. (“Amedisys”). This Filed by Option Care Health, Inc. Pursuant to Rule 425 of the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934 Subject Company: Amedisys, Inc. Commission File No.: 000-24260 Explanatory Note: The following is a presentation by Option Care Health, Inc. posted to a website hosted at www.optioncarehealthamedisys.com in connection with the proposed
May 15, 2023	425	## Filed by Option Care Health, Inc. Pursuant to Rule 425 of the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934 Subject Company: Amedisys, Inc. Commission File No.: 000-24260 Explanatory Note: The following are screenshots of new web pages added to the website hosted at www.optioncarehealthamedisys.com in connection with the proposed merger of O
May 10, 2023	425	Filed by Option Care Health, Inc. Filed by Option Care Health, Inc. Pursuant to Rule 425 of the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934 Subject Company: Amedisys, Inc. Commission File No.: 000-24260 Explanatory Note: The following is a transcript of a presentation by Option Care Health, Inc. at the BofA Securities Health Care Conference 2023. Option Care Health BofA Se
May 5, 2023	425	Filed by Option Care Health, Inc. Filed by Option Care Health, Inc. Pursuant to Rule 425 of the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934 Subject Company: Amedisys, Inc. Commission File No.: 000-24260 Explanatory Note: The following is a transcript of an employee townhall held by Option Care Health, Inc. on May 4, 2023. Welcome to you all! I cannot be more excited to wel
May 4, 2023	425	Option Care Health and Amedisys Transaction May 03, 2023 Filed by Option Care Health, Inc. Pursuant to Rule 425 of the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934 Subject Company: Amedisys, Inc. Commission File No.: 000-24260 Explanatory Note: The following is a transcript of an investor call held by Option Care Health, Inc. and Amedisys, Inc. on May 3, 2023. Option Care Health and Amedisys Tran
May 4, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-11993 OPTION CA
May 4, 2023	425	Filed by Option Care Health, Inc. Filed by Option Care Health, Inc. Pursuant to Rule 425 of the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934 Subject Company: Amedisys, Inc. Commission File No.: 000-24260 Explanatory Note: The following are screenshots of a website hosted at www.optioncarehealthamedisys.com in connection with the proposed merger of Option Care Health, Inc. a
May 4, 2023	EX-10.4	Commitment Letter, dated as of May 3, 2023, by and between Option Care Health, Inc. and Goldman Sachs Bank USA. Execution Version GOLDMAN SACHS BANK USA 200 West Street New York, New York 10282 May 3, 2023 Option Care Health, Inc.
May 4, 2023	425	Filed by Option Care Health, Inc. Filed by Option Care Health, Inc. Pursuant to Rule 425 of the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934 Subject Company: Amedisys, Inc. Commission File No.: 000-24260 Explanatory Note: The following LinkedIn and Facebook posts were issued by Option Care Health, Inc. on May 3, 2023. LinkedIn Post 05.03.2023 Facebook Post 05.03.2023 No Off
May 4, 2023	425	Filed by Option Care Health, Inc. Filed by Option Care Health, Inc. Pursuant to Rule 425 of the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934 Subject Company: Amedisys, Inc. Commission File No.: 000-24260 Explanatory Note: The following is an email communication made by Option Care Health, Inc. to Amedisys, Inc.’s employees on May 4, 2023. Amedisys Team, On behalf of my coll
May 4, 2023	425	Option Care Health and Amedisys Transaction May 03, 2023 Filed by Amedisys, Inc. Pursuant to Rule 425 of the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934 Subject Company: Option Care Health, Inc. Commission File No.: 000-11993 Explanatory Note: The following is a transcript of an investor call held by Amedisys, Inc. and Option Care Health, Inc. on May 3, 2023. Option Care Health and Amedisys Tran
May 3, 2023	425	Filed by Option Care Health, Inc. Filed by Option Care Health, Inc. Pursuant to Rule 425 of the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934 Subject Company: Amedisys, Inc. Commission File No.: 000-24260 Explanatory Note: The following is an email communication made by Option Care Health, Inc. to its employees on May 3, 2023. Subject: Option Care Health to Combine with Amed
May 3, 2023	425	Filed by Option Care Health, Inc. Filed by Option Care Health, Inc. Pursuant to Rule 425 of the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934 Subject Company: Amedisys, Inc. Commission File No.: 000-24260 Explanatory Note: The following are materials provided by Option Care Health, Inc. to its employees on May 3, 2023. 1. Why are Option Care Health and Amedisys combining? ·
May 3, 2023	425	Filed by Option Care Health, Inc. Filed by Option Care Health, Inc. Pursuant to Rule 425 of the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934 Subject Company: Amedisys, Inc. Commission File No.: 000-24260 Explanatory Note: The following infographic is being filed in connection with the proposed merger of Option Care Health, Inc. and Amedisys, Inc.
May 3, 2023	EX-2.1	Agreement and Plan of Merger, dated as of May 3, 2023, by and among Option Care Health, Inc., Uintah Merger Sub, Inc., and Amedisys, Inc. Exhibit 2.1 Execution Version AGREEMENT AND PLAN OF MERGER by and among OPTION CARE HEALTH, INC., UINTAH MERGER SUB, INC. and AMEDISYS, INC. dated as of May 3, 2023 TABLE OF CONTENTS Page Article I THE MERGER 2 Section 1.1. The Merger 2 Section 1.2. Closing 2 Section 1.3. Effective Time 2 Section 1.4. Effects of the Transaction 2 Section 1.5. Intended Tax Treatment 2 Article II DIRECTORS AND OFFIC
May 3, 2023	EX-99.1	OPTION CARE HEALTH ANNOUNCES FINANCIAL RESULTS FOR THE FIRST QUARTER ENDED MARCH 31, 2023 Exhibit 99.1 OPTION CARE HEALTH ANNOUNCES FINANCIAL RESULTS FOR THE FIRST QUARTER ENDED MARCH 31, 2023 BANNOCKBURN, IL., May 3, 2023 - Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today financial results for the first quarter ended March 31, 2023. First Quarter 2023
May 3, 2023	EX-99.2	Investor Presentation May 3, 2023 + Exhibit 99.2 Investor Presentation May 3, 2023 + + Disclaimer 2 No Offer or Solicitation This communication relates to the proposed merger (the “proposed transaction”) between Option Care Health, Inc . (“Option Care Health”) and Amedisys, Inc . (“Amedisys”) . This communication is not intended to and does not constitute an offer to sell or the solicitation of an offer to sell or the solicitation o
May 3, 2023	425	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 3, 2023 OPTION CARE HEALTH, IN UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 3, 2023 OPTION CARE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-11993 05-0489664 (State or other jurisdiction of incorporation) (Commission Fil
May 3, 2023	EX-99.1	Option Care Health and Amedisys to Combine Creating a Leading, Independent Platform for Home and Alternate Site Care All-Stock Transaction Combines Highly Complementary Businesses Unlocking Significant Benefits for Patients, Providers, Payers, and Ca Exhibit 99.1 Option Care Health and Amedisys to Combine Creating a Leading, Independent Platform for Home and Alternate Site Care All-Stock Transaction Combines Highly Complementary Businesses Unlocking Significant Benefits for Patients, Providers, Payers, and Care Teams Increases Access to High Quality Care for Communities Across the U.S. through a Unique National Clinical Platform Comprehensive
May 3, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 3, 2023 OPTION CARE HEALTH, IN UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 3, 2023 OPTION CARE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-11993 05-0489664 (State or other jurisdiction of incorporation) (Commission Fil
May 3, 2023	425	Filed by Option Care Health, Inc. 425 1 tm2314202d3425.htm 425 Filed by Option Care Health, Inc. Pursuant to Rule 425 of the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934 Subject Company: Amedisys, Inc. Commission File No.: 000-24260 Explanatory Note: The following is an email communication from Option Care Health, Inc. to health care providers. [NAME], Thank you for reachin
May 3, 2023	425	Filed by Option Care Health, Inc. Filed by Option Care Health, Inc. Pursuant to Rule 425 of the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934 Subject Company: Amedisys, Inc. Commission File No.: 000-24260 Explanatory Note: The following is an email communication from Option Care Health, Inc. to health systems, clinics and customers. [NAME], Thank you for reaching out. As you
May 3, 2023	425	Filed by Option Care Health, Inc. Filed by Option Care Health, Inc. Pursuant to Rule 425 of the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934 Subject Company: Amedisys, Inc. Commission File No.: 000-24260 Explanatory Note: The following is an email communication made by Option Care Health, Inc. to investors and analysts on May 3, 2023. SUBJECT: Option Care Health Q1 Earnings
May 3, 2023	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 3, 2023 OPTION CARE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-11993 05-0489664 (State or other jurisdiction of incorporation) (Commission Fil
April 7, 2023	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defin
April 7, 2023	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule
March 3, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 28, 2023 OPTION CARE HEAL UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 28, 2023 OPTION CARE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-11993 05-0489664 (State or other jurisdiction of incorporation) (Commissi
March 3, 2023	EX-FILING FEES	EX-FILING FEES Exhibit 107 The prospectus to which this Exhibit 107 is attached is a final prospectus for the related offering. The maximum aggregate offering price for such offering is $399,750,000.
March 3, 2023	EX-1.1	Underwriting Agreement, dated as of March 1, 2023, by and among Option Care Health, Inc., HC Group Holdings I, LLC and Goldman Sachs & Co. LLC. Exhibit 1.1 Execution Version Option Care Health, Inc. 13,000,000 Shares of Common Stock, par value $0.0001 per share Underwriting Agreement March 1, 2023 Goldman Sachs & Co. LLC 200 West Street New York, NY 10282 Ladies and Gentlemen: HC Group Holdings I, LLC (the “Selling Stockholder”), a stockholder of Option Care Health, Inc., a Delaware corporation (the “Company”), proposes to sell to the und
March 3, 2023	SC 13D/A	OPCH / Option Care Health Inc. - Registered Shares / Walgreens Boots Alliance, Inc. - SC 13D/A Activist Investment SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 2)* Option Care Health, Inc. (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securities) 68404L201 (CUSIP Number) Danielle C. Gray Executive Vice President, Global Chief Legal Officer Walgreens Boots Alliance, Inc. 108 Wilmot R
March 3, 2023	EX-10.1	Share Repurchase Agreement, dated as of February 28, 2023, by and between Option Care Health, Inc. and HC Group Holdings I, LLC (incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K filed on March 3, 2023). Exhibit 10.1 SHARE REPURCHASE AGREEMENT This SHARE REPURCHASE AGREEMENT (this “Agreement”) is entered into as of February 28, 2023 by and between Option Care Health, Inc., a Delaware corporation (the “Company”), and HC Group Holdings I, LLC, a Delaware limited liability company and a stockholder of the Company (the “Selling Stockholder”). Background A. The Selling Stockholder owns an aggregate of
March 3, 2023	424B4	13,000,000 Shares Common Stock Filed Pursuant to Rule 424(b)(4) Registration Statement No. 333-239504 PROSPECTUS SUPPLEMENT (to Prospectus dated July 8, 2020) 13,000,000 Shares Common Stock The selling stockholder identified in this prospectus supplement is offering 13,000,000 shares of our common stock. We will not receive any of the proceeds from the shares of common stock sold by the selling stockholder. We have entered into
March 1, 2023	FWP	OPTION CARE HEALTH ANNOUNCES SECONDARY OFFERING OF 13,000,000 SHARES OF COMMON STOCK AND COMMON STOCK REPURCHASE Free Writing Prospectus dated March 1, 2023 Relating to Prospectus dated July 8, 2020 Filed Pursuant to Rule 433 under the Securities Act of 1933 Registration Statement No.
February 23, 2023	EX-99.1	OPTION CARE HEALTH REPORTS FINANCIAL RESULTS FOR FOURTH QUARTER AND FULL YEAR 2022 AND ANNOUNCES SHARE REPURCHASE AUTHORIZATION Exhibit 99.1 OPTION CARE HEALTH REPORTS FINANCIAL RESULTS FOR FOURTH QUARTER AND FULL YEAR 2022 AND ANNOUNCES SHARE REPURCHASE AUTHORIZATION BANNOCKBURN, IL., February 23, 2023 - Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today financial results for the fourth qua
February 23, 2023	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 23, 2023 OPTION CARE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-11993 05-0489664 (State or other jurisdiction of incorporation) (Commissi
February 23, 2023	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-11993 OPTION CARE HE
February 23, 2023	EX-10.5	Option Care Health, Inc. Executive Severance Plan, effective as of May 11, 2020 (filed herewith). Executive Severance Plan As in effect as of May 11, 2020. The company reserves the right to amend, modify, or terminate this Plan at any time and for any reason. 1 Introduction The purpose of this Executive Severance Plan is to provide financial assistance to eligible executives (each a “Participant”) of the Option Care Health family of companies (the “Company”) who terminate employment in qualify
February 23, 2023	EX-21.1	List of subsidiaries of Option Care Health, Inc. (filed herewith). EXHIBIT 21.1 OPTION CARE HEALTH, INC. AND ITS SUBSIDIARIES Entity Name State of Incorporation Doing Business As Applied Health Care, LLC Delaware Option Care Health BioScrip Infusion Services, Inc. California Option Care Health BioScrip Infusion Services, LLC Delaware Option Care Health BioScrip PBM Services, LLC Delaware Option Care Health BioScrip Pharmacy (NY), Inc. New York Option Care Health
February 9, 2023	SC 13G/A	OPCH / Option Care Health Inc / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SC 13G/A 1 tv01590-optioncarehealthinc.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 1)* Name of issuer: Option Care Health Inc. Title of Class of Securities: Common Stock CUSIP Number: 68404L201 Date of Event Which Requires Filing of this Statement: December 30, 2022 Check the appropriate box to
January 19, 2023	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 13, 2023 OPTION CARE HEALTH, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-11993 05-0489664 (Commissio
January 19, 2023	EX-10.1	Fourth Amendment to ABL Credit Agreement, dated as of January 13, 2023, among Option Care Health, Inc. (f/k/a BioScrip, Inc.), a Delaware corporation, each guarantor party thereto, each lender party thereto and Bank of America, N.A., as administrative agent. Exhibit 10.1 Execution Version FOURTH AMENDMENT TO ABL CREDIT AGREEMENT This FOURTH AMENDMENT TO ABL CREDIT AGREEMENT, dated as of January 13, 2023 (this “Amendment”), among Option Care Health, Inc. (f/k/a BioScrip, Inc.), a Delaware corporation (the “Parent Borrower” and a “Borrower”), each Guarantor party hereto, each Lender party hereto and Bank of America, N.A., as administrative agent (in suc
October 27, 2022	EX-99.1	OPTION CARE HEALTH ANNOUNCES FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2022 Exhibit 99.1 OPTION CARE HEALTH ANNOUNCES FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2022 BANNOCKBURN, IL., October 27, 2022 - Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, today announced financial results for the third quarter ended September 30, 2022. Third
October 27, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-11993 OPTIO
October 27, 2022	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) October 27, 2022 OPTION CARE HEALT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) October 27, 2022 OPTION CARE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-11993 05-0489664 (State or other jurisdiction of incorporation) (Commissio
September 30, 2022	EX-3.1	Third Amended and Restated Bylaws of Option Care Health, Inc. (incorporated by reference to Exhibit 3.1 to the Company's Current Report on Form 8-K filed on September 30, 2022). Exhibit 3.1 THIRD AMENDED AND RESTATED BY-LAWS of OPTION CARE HEALTH, INC. (A Delaware Corporation) ARTICLE 1 Offices Section 1.1 Offices. The Corporation may have offices at such places both within and without the State of Delaware as the Board of Directors may from time to time determine or the business of the Corporation may require. ARTICLE 2 Meetings of Stockholders Section 2.1 Place of Meeti
September 30, 2022	8-K	Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) September 29, 2022 OPTION CARE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-11993 05-0489664 (State or other jurisdiction of incorporation) (Commiss
August 18, 2022	424B4	11,000,000 Shares Common Stock TABLE OF CONTENTS ?Filed Pursuant to Rule 424(b)(4) ?Registration Statement No. 333-239504? PROSPECTUS SUPPLEMENT (to Prospectus dated July 8, 2020) 11,000,000 Shares Common Stock The selling stockholder identified in this prospectus supplement is offering 11,000,000 shares of our common stock. We will not receive any of the proceeds from the shares of common stock sold by the selling stockholder.
August 18, 2022	EX-1.1	Underwriting Agreement, dated as of August 16, 2022, by and among Option Care Health, Inc., HC Group Holdings I, LLC and Goldman Sachs & Co. LLC. Exhibit 1.1 Option Care Health, Inc. 11,000,000 Shares of Common Stock, par value $0.0001 per share Underwriting Agreement August 16, 2022 Goldman Sachs & Co. LLC 200 West Street New York, NY 10282 Ladies and Gentlemen: HC Group Holdings I, LLC (the ?Selling Stockholder?), a stockholder of Option Care Health, Inc., a Delaware corporation (the ?Company?), proposes to sell to the underwriters set fo
August 18, 2022	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 16, 2022 OPTION CARE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-11993 05-0489664 (State or other jurisdiction of incorporation) (Commission
August 18, 2022	SC 13D/A	OPCH / Option Care Health Inc / Walgreens Boots Alliance, Inc. - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* Option Care Health, Inc. (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securities) 68404L201 (CUSIP Number) Danielle C. Gray Executive Vice President, Global Chief Legal Officer Walgreens Boots Alliance, Inc. 108 Wilmot Road Deerf
August 18, 2022	EX-FILING FEES	EX-FILING FEES Exhibit 107 The prospectus to which this Exhibit 107 is attached is a final prospectus for the related offering. The maximum aggregate offering price for such offering is $365,750,000.
July 27, 2022	EX-99.1	OPTION CARE HEALTH ANNOUNCES FINANCIAL RESULTS FOR THE SECOND QUARTER ENDED JUNE 30, 2022 Exhibit 99.1 OPTION CARE HEALTH ANNOUNCES FINANCIAL RESULTS FOR THE SECOND QUARTER ENDED JUNE 30, 2022 BANNOCKBURN, IL., July 27, 2022 - Option Care Health, Inc. (the ?Company? or ?Option Care Health?) (Nasdaq: OPCH), the nation?s largest independent provider of home and alternate site infusion services, today announced financial results for the second quarter ended June 30, 2022. Second Quarter 2
July 27, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-11993 OPTION CAR
July 27, 2022	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 27, 2022 OPTION CARE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-11993 05-0489664 (State or other jurisdiction of incorporation) (Commission F
May 20, 2022	8-K	Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 18, 2022 OPTION CARE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-11993 05-0489664 (State or other jurisdiction of incorporation) (Commission Fi
April 28, 2022	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 28, 2022 OPTION CARE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-11993 05-0489664 (State or other jurisdiction of incorporation) (Commission
April 28, 2022	EX-99.1	OPTION CARE HEALTH ANNOUNCES FINANCIAL RESULTS FOR THE FIRST QUARTER ENDED MARCH 31, 2022 Exhibit 99.1 OPTION CARE HEALTH ANNOUNCES FINANCIAL RESULTS FOR THE FIRST QUARTER ENDED MARCH 31, 2022 BANNOCKBURN, IL., April 28, 2022 - Option Care Health, Inc. (the ?Company? or ?Option Care Health?) (Nasdaq: OPCH), the nation?s largest independent provider of home and alternate site infusion services, today announced financial results for the first quarter ended March 31, 2022. First Quarter 2
April 28, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-11993 OPTION CA
April 6, 2022	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ??) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Def
April 6, 2022	DEF 14A	Definitive Proxy Statement on Schedule 14A, filed with the SEC on April 6, 2022 TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6
March 29, 2022	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) March 25, 2022 OPTION CARE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-11993 05-0489664 (State or other jurisdiction of incorporation) (Commission
February 23, 2022	EX-21.1	List of subsidiaries of Option Care Health, Inc. (filed herewith). EXHIBIT 21.1 OPTION CARE HEALTH, INC. AND ITS SUBSIDIARIES Entity Name State of Incorporation Doing Business As Applied Health Care, LLC Delaware Option Care Health BioScrip Infusion Services, Inc. California Option Care Health BioScrip Infusion Services, LLC Delaware Option Care Health BioScrip Medical Supply Services, LLC Delaware Option Care Health BioScrip PBM Services, LLC Delaware Option Car
February 23, 2022	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-11993 OPTION CARE HE
February 23, 2022	EX-99.1	OPTION CARE HEALTH REPORTS FINANCIAL RESULTS FOR FOURTH QUARTER AND FULL YEAR 2021 AND ANNOUNCES TWO ADDITIONAL ACQUISITIONS Exhibit 99.1 OPTION CARE HEALTH REPORTS FINANCIAL RESULTS FOR FOURTH QUARTER AND FULL YEAR 2021 AND ANNOUNCES TWO ADDITIONAL ACQUISITIONS BANNOCKBURN, IL., February 23, 2022 - Option Care Health, Inc. (the ?Company? or ?Option Care Health?) (Nasdaq: OPCH), the nation?s largest independent provider of home and alternate site infusion services, announced today financial results for the fourth quarte
February 23, 2022	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 23, 2022 OPTION CARE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-11993 05-0489664 (State or other jurisdiction of incorporation) (Commissi
February 10, 2022	SC 13G	OPCH / Option Care Health Inc / VANGUARD GROUP INC - SCHEDULE 13G Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 Name of issuer: Option Care Health Inc. Title of Class of Securities: Common Stock CUSIP Number: 68404L201 Date of Event Which Requires Filing of this Statement: December 31, 2021 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Rule 13d-1(b) ☐
December 20, 2021	SC 13D	OPCH / Option Care Health Inc / Walgreens Boots Alliance, Inc. - SC 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 Option Care Health, Inc. (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securities) 68404L201 (CUSIP Number) Danielle C. Gray Executive Vice President and Global Chief Legal Officer 108 Wilmot Road Deerfield, Illinois 60015 (847) 315-2500 with a copy t
December 20, 2021	EX-1	Joint Filing Agreement, by and among the Reporting Persons, dated as of December 20, 2021(incorporated by reference to Exhibit 1 of the Schedule 13D filed by the Reporting Persons on December 20, 2021). EXHIBIT 1 JOINT FILING AGREEMENT Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13D need be filed with respect to the ownership by each of the undersigned of shares of Option Care Health, Inc.
December 20, 2021	SC 13D/A	OPCH / Option Care Health Inc / MADISON DEARBORN PARTNERS LLC - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A (Amendment No. 10)* Under the Securities Exchange Act of 1934 Option Care Health, Inc. (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securities) 68404L 201 (CUSIP Number) Joshua Korff, P.C. Ross Leff, P.C. Kirkland & Ellis LLP 601 Lexington Avenue New York, New York 10022 (212) 446-4800 (Na
November 10, 2021	424B7	OPTION CARE HEALTH, INC. SUPPLEMENT TO PROSPECTUS DATED JULY 8, 2020 THE DATE OF THIS PROSPECTUS SUPPLEMENT IS NOVEMBER 10, 2021 TABLE OF CONTENTS ?FILED PURSUANT TO RULE 424(B)(7)? ?FILE NO. 333-239504? OPTION CARE HEALTH, INC. SUPPLEMENT TO PROSPECTUS DATED JULY 8, 2020 THE DATE OF THIS PROSPECTUS SUPPLEMENT IS NOVEMBER 10, 2021 This prospectus supplement (this ?Prospectus Supplement?) is part of the prospectus of Option Care Health, Inc. (the ?Company?), dated July 8, 2020 (as previously supplemented, the ?Prospectus?).
November 4, 2021	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-11993 OPTIO
November 4, 2021	EX-99.1	OPTION CARE HEALTH ANNOUNCES FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2021 Exhibit 99.1 OPTION CARE HEALTH ANNOUNCES FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2021 BANNOCKBURN, IL., November 4, 2021 - Option Care Health, Inc. (the ?Company? or ?Option Care Health?) (Nasdaq: OPCH), the nation?s largest independent provider of home and alternate site infusion services, announced today financial results for the third quarter ended September 30, 2021. Third
November 4, 2021	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 4, 2021 OPTION CARE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-11993 05-0489664 (State or other jurisdiction of incorporation) (Commissio
October 29, 2021	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 27, 2021 OPTION CARE HEALTH, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-11993 05-0489664 (Commissi
October 29, 2021	EX-10.2	Third Amendment to ABL Credit Agreement, dated as of October 27, 2021 (incorporated by reference to Exhibit 10.2 of the Company's Current Report on Form 8-K filed on October 29, 2021). Exhibit 10.2 Execution Version Third AMENDMENT TO ABL CREDIT AGREEMENT This THIRD AMENDMENT TO ABL CREDIT AGREEMENT, dated as of October 27, 2021 (this ?Amendment?), among Option Care Health, Inc. (f/k/a BioScrip, Inc.), a Delaware corporation (the ?Parent Borrower? and a ?Borrower?), each Guarantor party hereto, each Lender party hereto and Bank of America, N.A., as administrative agent (in such
October 29, 2021	EX-4.1	Indenture, dated as of October 27, 2021, by and between Option Care Health, Inc., each of the Guarantors (as defined therein) listed on the signature pages thereto and Ankura Trust Company, LLC as trustee (incorporated by reference to Exhibit 4.1 of the Company’s Current Report on Form 8-K filed on October 29, 2021). Exhibit 4.1 EXECUTION VERSION OPTION CARE HEALTH, INC. AND ANKURA TRUST COMPANY, LLC as Trustee 4?% Senior Notes due 2029 INDENTURE Dated as of October 27, 2021 Table of Contents Page Article I DEFINITIONS AND INCORPORATION BY REFERENCE Section 1.1. Definitions 1 Section 1.2. Other Definitions 52 Section 1.3. [Reserved] 55 Section 1.4. Rules of Construction 55 Article II THE NOTES Section 2.1. For
October 29, 2021	EX-10.1	Second Amendment and Amendment and Restatement Agreement to First Lien Credit Agreement, dated as of October 27, 2021 (incorporated by reference to Exhibit 10.1 of the Company's Current Report on Form 8-K filed on October 29, 2021). Exhibit 10.1 Execution Version SECOND AMENDMENT AND AMENDMENT AND RESTATEMENT AGREEMENT TO FIRST LIEN CREDIT AGREEMENT This SECOND AMENDMENT AND AMENDMENT AND RESTATEMENT AGREEMENT TO FIRST LIEN CREDIT AGREEMENT, dated as of October 27, 2021 (this ?Amendment Agreement?), among Option Care Health, Inc. (f/k/a BioScrip, Inc.), a Delaware corporation (the ?Parent Borrower?), the Guarantors party here
October 25, 2021	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 22, 2021 OPTION CARE HEALTH, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-11993 05-0489664 (Commissi
October 25, 2021	EX-10.1	Purchase Agreement, dated October 22, 2021 Exhibit 10.1 EXECUTION VERSION PURCHASE AGREEMENT October 22, 2021 BofA Securities, Inc. As representative of the Initial Purchasers c/o BofA Securities, Inc. One Bryant Park New York, New York 10036 Ladies and Gentlemen: Introductory. Option Care Health, Inc., a Delaware corporation (the ?Company?), proposes to issue and sell to BofA Securities, Inc. (?BofAS?) and the other several Initial Purcha
October 25, 2021	EX-99.1	OPTION CARE HEALTH ANNOUNCES PRICING OF OFFERING OF $500 MILLION 4.375% SENIOR NOTES AND AMENDMENT AND EXTENSION OF FIRST LIEN TERM LOAN Exhibit 99.1 OPTION CARE HEALTH ANNOUNCES PRICING OF OFFERING OF $500 MILLION 4.375% SENIOR NOTES AND AMENDMENT AND EXTENSION OF FIRST LIEN TERM LOAN BANNOCKBURN, Ill., October 22, 2021 - Option Care Health, Inc. (NASDAQ: OPCH) (?Option Care Health? or the ?Company?) announced today that it priced its offering of $500 million in aggregate principal amount of 4.375% senior notes due 2029 (the ?Note
October 20, 2021	EX-99.1	OPTION CARE HEALTH ANNOUNCES OFFERING OF $500 MILLION OF SENIOR NOTES AND AMENDMENT AND EXTENSION OF FIRST LIEN TERM LOAN Exhibit 99.1 OPTION CARE HEALTH ANNOUNCES OFFERING OF $500 MILLION OF SENIOR NOTES AND AMENDMENT AND EXTENSION OF FIRST LIEN TERM LOAN BANNOCKBURN, Ill., October 20, 2021 - Option Care Health, Inc. (NASDAQ: OPCH) (?Option Care Health? or the ?Company?) announced today that it intends to offer $500 million in aggregate principal amount of senior notes due 2029 (the ?Notes?), subject to market and o
October 20, 2021	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 20, 2021 OPTION CARE HEALTH, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-11993 05-0489664 (Commissi
October 20, 2021	EX-99.1	OPTION CARE HEALTH ANNOUNCES PRELIMINARY FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2021 AND SCHEDULES THIRD QUARTER EARNINGS CALL Exhibit 99.1 OPTION CARE HEALTH ANNOUNCES PRELIMINARY FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2021 AND SCHEDULES THIRD QUARTER EARNINGS CALL BANNOCKBURN, Ill., October 20, 2021 - Option Care Health, Inc. (NASDAQ: OPCH) (?Option Care Health? or the ?Company?), the nation?s largest independent provider of home and alternate site infusion services, announced today its preliminary
October 20, 2021	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 20, 2021 OPTION CARE HEALTH, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-11993 05-0489664 (Commissi
September 22, 2021	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) September 17, 2021 OPTION CARE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-11993 05-0489664 (State or other jurisdiction of incorporation) (Commiss
September 13, 2021	SC 13D/A	OPCH / Option Care Health Inc / MADISON DEARBORN PARTNERS LLC - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A (Amendment No. 9)* Under the Securities Exchange Act of 1934 Option Care Health, Inc. (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securities) 68404L 102 (CUSIP Number) Joshua Korff, P.C. Ross Leff, P.C. Kirkland & Ellis LLP 601 Lexington Avenue New York, New York 10022 (212) 446-4800 (Nam
September 9, 2021	EX-1.1	Underwriting Agreement, dated as of September 7, 2021, by and among Option Care Health, Inc., HC Group Holdings I, LLC and Goldman Sachs & Co. LLC. Exhibit 1.1 Execution Version Option Care Health, Inc. 9,200,000 Shares of Common Stock, par value $0.0001 per share Underwriting Agreement September 7, 2021 Goldman Sachs & Co. LLC 200 West Street New York, NY 10282 Ladies and Gentlemen: HC Group Holdings I, LLC (the ?Selling Stockholder?), a stockholder of Option Care Health, Inc., a Delaware corporation (the ?Company?), proposes to sell to the
September 9, 2021	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) September 7, 2021 OPTION CARE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-11993 05-0489664 (State or other jurisdiction of (Commission File Number)
September 9, 2021	424B4	9,200,000 Shares Common Stock TABLE OF CONTENTS ?Filed Pursuant to Rule 424(b)(4)? ?Registration Statement No. 333-239504? PROSPECTUS SUPPLEMENT (to Prospectus dated July 8, 2020) 9,200,000 Shares Common Stock The selling stockholder identified in this prospectus supplement is offering 9,200,000 shares of our common stock. We will not receive any of the proceeds from the shares of common stock sold by the selling stockholder.
August 16, 2021	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 11, 2021 OPTION CARE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-11993 05-0489664 (State or other jurisdiction of incorporation) (Commission
August 6, 2021	SC 13D/A	OPCH / Option Care Health Inc / MADISON DEARBORN PARTNERS LLC - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A (Amendment No. 8)* Under the Securities Exchange Act of 1934 Option Care Health, Inc. (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securities) 68404L 102 (CUSIP Number) Joshua Korff, P.C. Ross Leff, P.C. Kirkland & Ellis LLP 601 Lexington Avenue New York, New York 10022 (212) 446-4800 (Nam
August 5, 2021	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 3, 2021 OPTION CARE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-11993 05-0489664 (State or other jurisdiction of (Commission File Number) (I
August 5, 2021	424B4	18,000,000 Shares Common Stock TABLE OF CONTENTS ? Filed Pursuant to Rule 424(b)(4)? ?Registration Statement No. 333-239504? PROSPECTUS SUPPLEMENT (to Prospectus dated July 8, 2020) 18,000,000 Shares Common Stock The selling stockholder identified in this prospectus supplement is offering 18,000,000 shares of our common stock. We will not receive any of the proceeds from the shares of common stock sold by the selling stockholde
August 5, 2021	EX-1.1	Underwriting Agreement, dated as of August 3, 2021, by and among Option Care Health, Inc., HC Group Holdings I, LLC and Goldman Sachs & Co. LLC. Exhibit 1.1 Execution Version Option Care Health, Inc. 18,000,000 Shares of Common Stock, par value $0.0001 per share Underwriting Agreement August 3, 2021 Goldman Sachs & Co. LLC 200 West Street New York, NY 10282 Ladies and Gentlemen: HC Group Holdings I, LLC (the ?Selling Stockholder?), a stockholder of Option Care Health, Inc., a Delaware corporation (the ?Company?), proposes to sell to the un
August 3, 2021	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-11993 OPTION CAR
August 3, 2021	10-Q/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q/A (Amendment No. 1) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q/A (Amendment No. 1) (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number:
August 3, 2021	EX-10.1	Option Care Health, Inc. 2018 Equity Incentive Plan updated as of May 19, 2021 (incorporated by reference to Exhibit 10.1 of the Company’s Quarterly Report on Form 10-Q/A filed on August 3, 2021). Option Care Health, Inc. 2018 Equity Incentive Plan Amended and Restated as of May 19, 2021 TABLE OF CONTENTS SECTION 1. BACKGROUND AND PURPOSE........................................................................... 1 SECTION 2. DEFINITIONS.......................................................................................................... 1 2.1.Affiliate...................................
August 3, 2021	EX-99.1	OPTION CARE HEALTH ANNOUNCES FINANCIAL RESULTS FOR THE SECOND QUARTER ENDED JUNE 30, 2021 Exhibit 99.1 OPTION CARE HEALTH ANNOUNCES FINANCIAL RESULTS FOR THE SECOND QUARTER ENDED JUNE 30, 2021 BANNOCKBURN, IL., August 3, 2021 - Option Care Health, Inc. (the ?Company? or ?Option Care Health?) (Nasdaq: OPCH), the nation?s largest independent provider of home and alternate site infusion services, announced today financial results for the second quarter ended June 30, 2021. Second Quarter
August 3, 2021	EX-10.1	Option Care Health, Inc. 2018 Equity Incentive Option Care Health, Inc. 2018 Equity Incentive Plan Amended and Restated as of May 19, 2021 TABLE OF CONTENTS SECTION 1. BACKGROUND AND PURPOSE........................................................................... 1 SECTION 2. DEFINITIONS.......................................................................................................... 1 2.1.Affiliate...................................
August 3, 2021	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 3, 2021 OPTION CARE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-11993 05-0489664 (State or other jurisdiction of incorporation) (Commission
June 14, 2021	SC 13D/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A (Amendment No. 7)* Under the Securities Exchange Act of 1934 Option Care Health, Inc. (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securitie UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A (Amendment No. 7)* Under the Securities Exchange Act of 1934 Option Care Health, Inc. (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securities) 68404L 102 (CUSIP Number) Joshua Korff, P.C. Ross Leff, P.C. Kirkland & Ellis LLP 601 Lexington Avenue New York, New York 10022 (212) 446-4800 (Nam
June 10, 2021	424B4	15,000,000 Shares Common Stock TABLE OF CONTENTS ?Filed Pursuant to Rule 424(b)(4)? ?Registration No. 333-239504? PROSPECTUS SUPPLEMENT (to Prospectus dated July 8, 2020) 15,000,000 Shares Common Stock The selling stockholder identified in this prospectus supplement is offering 15,000,000 shares of our common stock. We will not receive any of the proceeds from the shares of common stock sold by the selling stockholder. Our comm
June 10, 2021	EX-1.1	Underwriting Agreement, dated as of June 8, 2021, by and among Option Care Health, Inc., HC Group Holdings I, LLC and Goldman Sachs & Co. LLC. Exhibit 1.1 Option Care Health, Inc. 15,000,000 Shares of Common Stock, par value $0.0001 per share Underwriting Agreement June 8, 2021 Goldman Sachs & Co. LLC 200 West Street New York, NY 10282 Ladies and Gentlemen: HC Group Holdings I, LLC (the ?Selling Stockholder?), a stockholder of Option Care Health, Inc., a Delaware corporation (the ?Company?), proposes to sell to the underwriters set forth
June 10, 2021	8-K	Other Events, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) June 8, 2021 OPTION CARE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-11993 05-0489664 (State or other jurisdiction of (Commission File Number) (I.R
May 21, 2021	8-K	Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 19, 2021 OPTION CARE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-11993 05-0489664 (State or other jurisdiction of incorporation) (Commission Fi
May 6, 2021	10-Q	Quarterly Report - 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-11993 OPTION CA
May 6, 2021	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 6, 2021 OPTION CARE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-11993 05-0489664 (State or other jurisdiction of incorporation) (Commission Fil
May 6, 2021	EX-99.1	OPTION CARE HEALTH ANNOUNCES FINANCIAL RESULTS FOR THE FIRST QUARTER ENDED MARCH 31, 2021 Exhibit 99.1 OPTION CARE HEALTH ANNOUNCES FINANCIAL RESULTS FOR THE FIRST QUARTER ENDED MARCH 31, 2021 BANNOCKBURN, IL., May 6, 2021 - Option Care Health, Inc. (the ?Company? or ?Option Care Health?) (Nasdaq: OPCH), the nation?s largest independent provider of home and alternate site infusion services, announced today financial results for the first quarter ended March 31, 2021. First Quarter 2021
April 20, 2021	DEFA14A	- DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Defin
April 7, 2021	DEFA14A	- DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Defin
April 7, 2021	DEF 14A	Definitive Proxy Statement on Schedule 14A, filed with the SEC on April 7, 2021 TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? ? Check the appropriate box: ? Preliminary Proxy Statement ? ? Confidential, for Use of the Commission Only (as permitted by Rule 14a
March 19, 2021	SC 13D/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A (Amendment No. 6)* Under the Securities Exchange Act of 1934 Option Care Health, Inc. (Name of issuer) Common Stock, $0.0001 par value (Title of Class of Securitie UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A (Amendment No. 6)* Under the Securities Exchange Act of 1934 Option Care Health, Inc. (Name of issuer) Common Stock, $0.0001 par value (Title of Class of Securities) 68404L 102 (CUSIP number) Joshua Korff, P.C. Ross Leff, P.C. Kirkland & Ellis LLP 601 Lexington Avenue New York, New York 10022 (212) 446-4800 (Nam
March 17, 2021	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) March 15, 2021 OPTION CARE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-11993 05-0489664 (State or other jurisdiction of Commission File Number) (I.
March 17, 2021	EX-1.1	Exhibit 17 Exhibit 1.1 Execution Version Option Care Health, Inc. 12,000,000 Shares of Common Stock, par value $0.0001 per share Underwriting Agreement March 15, 2021 Goldman Sachs & Co. LLC 200 West Street New York, NY 10282 Ladies and Gentlemen: HC Group Holdings I, LLC (the ?Selling Stockholder?), a stockholder of Option Care Health, Inc., a Delaware corporation (the ?Company?), proposes to sell to the un
March 17, 2021	424B4	12,000,000 Shares Common Stock TABLE OF CONTENTS ?Filed Pursuant to Rule 424(b)(4) ?Registration No. 333-239504? PROSPECTUS SUPPLEMENT (to Prospectus dated July 8, 2020) 12,000,000 Shares Common Stock The selling stockholder identified in this prospectus supplement is offering 12,000,000 shares of our common stock. We will not receive any of the proceeds from the shares of common stock sold by the selling stockholder. Our commo
March 11, 2021	10-K	Annual Report - 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-11993 OPTION CARE HE
March 11, 2021	EX-21.1	List of subsidiaries of Option Care Health, Inc. (filed herewith). EXHIBIT 21.1 OPTION CARE HEALTH, INC. AND ITS SUBSIDIARIES Entity Name State of Incorporation Doing Business As Applied Health Care, LLC Delaware Option Care Health BioScrip Infusion Management, LLC Delaware Option Care Health BioScrip Infusion Services, Inc. California Option Care Health BioScrip Infusion Services, LLC Delaware Option Care Health BioScrip Medical Supply Services, LLC Delaware Opt
March 11, 2021	EX-10.13	Cliff Berman Employment Agreement entered into on August 3, 2015 (filed herewith). EXHIBIT 10.13 Executed Version EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (this "Agreement") is made as of August 3, 2015 by and between Walgreens Infusion Services, Inc., an Illinois corporation (the "Company"), and Cliff Berman ("Executive"). In consideration of the mutual covenants contained herein and other good and valuable consideration, the receipt and sufficiency of which are hereby ac
March 11, 2021	EX-99.1	OPTION CARE HEALTH ANNOUNCES FINANCIAL RESULTS FOR FOURTH QUARTER AND FULL YEAR 2020 AND PROVIDES GUIDANCE FOR FULL YEAR 2021 Exhibit 99.1 OPTION CARE HEALTH ANNOUNCES FINANCIAL RESULTS FOR FOURTH QUARTER AND FULL YEAR 2020 AND PROVIDES GUIDANCE FOR FULL YEAR 2021 BANNOCKBURN, IL., March 11, 2021 - Option Care Health, Inc. (the ?Company? or ?Option Care Health?) (Nasdaq: OPCH), the nation?s largest independent provider of home and alternate site infusion services, announced today financial results for the fourth quarter
March 11, 2021	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) March 11, 2021 OPTION CARE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-11993 05-0489664 (State or other jurisdiction of incorporation) (Commission
March 11, 2021	EX-10.12	Rich Denness Employment Agreement entered into on June 8, 2019 (filed herewith). EXHIBIT 10.12 Executed Version June 8, 2019 Rich Denness 1600 Broadway Suite 700 Denver, CO 80202 Dear Rich, We are pleased to offer you the position of Chief Strategy Officer at Option Care Enterprises, under the management of John Rademacher, the Chief Executive Officer, following the closing of the combination of Option Care Enterprises and BioScrip (the "Merger"). This offer is conditioned upo
February 12, 2021	SC 13D/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A (Amendment No. 5)* Under the Securities Exchange Act of 1934 Option Care Health, Inc. (Name of issuer) Common Stock, $0.0001 par value (Title of Class of Securitie UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A (Amendment No. 5)* Under the Securities Exchange Act of 1934 Option Care Health, Inc. (Name of issuer) Common Stock, $0.0001 par value (Title of Class of Securities) 68404L 102 (CUSIP number) Joshua Korff, P.C. Ross Leff, P.C. Kirkland & Ellis LLP 601 Lexington Avenue New York, New York 10022 (212) 446-4800 (Nam
February 10, 2021	424B4	15,000,000 Shares Common Stock TABLE OF CONTENTS Filed Pursuant to Rule 424(b)(4) Registration No. 333-239504 PROSPECTUS SUPPLEMENT (to Prospectus dated July 8, 2020) 15,000,000 Shares Common Stock The selling stockholder identified in this prospectus supplement is offering 15,000,000 shares of our common stock. We will not receive any of the proceeds from the shares of common stock sold by the selling stockholder. Our common
February 10, 2021	EX-1.1	Underwriting Agreement, dated as of February 8, 2021, by and among Option Care Health, Inc., HC Group Holdings I, LLC and Goldman Sachs & Co. LLC. Exhibit 1.1 Option Care Health, Inc. 15,000,000 Shares of Common Stock, par value $0.0001 per share Underwriting Agreement February 8, 2021 Goldman Sachs & Co. LLC 200 West Street New York, NY 10282 Ladies and Gentlemen: HC Group Holdings I, LLC (the “Selling Stockholder”), a stockholder of Option Care Health, Inc., a Delaware corporation (the “Company”), proposes to sell to the underwriters set f
February 10, 2021	8-K	Other Events, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 8, 2021 OPTION CARE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-11993 05-0489664 (State or other jurisdiction of Commission File Number) (
February 8, 2021	EX-99.1	OPTION CARE HEALTH ANNOUNCES PRELIMINARY FINANCIAL RESULTS FOR THE FOURTH QUARTER AND FISCAL YEAR AND SCHEDULES FOURTH QUARTER EARNINGS CALL Exhibit 99.1 OPTION CARE HEALTH ANNOUNCES PRELIMINARY FINANCIAL RESULTS FOR THE FOURTH QUARTER AND FISCAL YEAR AND SCHEDULES FOURTH QUARTER EARNINGS CALL BANNOCKBURN, Ill., February 8, 2021 – Option Care Health Inc. (“Option Care Health” or the “Company”) (NASDAQ: OPCH), the nation’s largest independent national provider of home and alternate site infusion services, announced today preliminary fin
February 8, 2021	8-K	Results of Operations and Financial Condition, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 8, 2021 OPTION CARE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-11993 05-0489664 (State or other jurisdiction of Commission File Number) (
February 8, 2021	424B4	Subject to Completion Preliminary Prospectus Supplement dated February 8, 2021 TABLE OF CONTENTS The information in this preliminary prospectus supplement and the accompanying prospectus is not complete and may be changed.
January 22, 2021	EX-10.2	Second Amendment to ABL Credit Agreement, dated as of January 21, 2021, by and among Option Care Health, Inc., the guarantors party thereto, Bank of America, N.A. and the financial institutions party thereto (incorporated by reference to Exhibit 10.2 of the Company's Current Report on Form 8-K filed on January 22, 2021). Exhibit 10.2 EXECUTION VERSION SECOND AMENDMENT TO ABL CREDIT AGREEMENT This SECOND AMENDMENT TO ABL CREDIT AGREEMENT, dated as of January 21, 2021 (this “Amendment”), among Option Care Health, Inc. (f/k/a BioScrip, Inc.), a Delaware corporation (the “Parent Borrower” and a “Borrower”), each Guarantor party hereto, each Lender party hereto and Bank of America, N.A., as administrative agent (in suc
January 22, 2021	8-K	Regulation FD Disclosure, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 21, 2021 OPTION CARE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-11993 05-0489664 (State or other jurisdiction of Commission File Number) (
January 22, 2021	EX-10.1	First Amendment to First Lien Credit Agreement, dated as of January 21, 2021, by and among Option Care Health, Inc., the guarantors party thereto, Bank of America, N.A. and the financial institutions party thereto Exhibit 10.1 EXECUTION VERSION First AMENDMENT TO FIRST LIEN CREDIT AGREEMENT This FIRST AMENDMENT TO FIRST LIEN CREDIT AGREEMENT, dated as of January 21, 2021 (this “Amendment”), among Option Care Health, Inc. (f/k/a BioScrip, Inc.), a Delaware corporation (the “Parent Borrower”), the Guarantors party hereto Bank of America, N.A., as Administrative Agent (the “Administrative Agent”), and each Len
January 22, 2021	EX-99.1	OPTION CARE HEALTH ANNOUNCES ISSUANCE OF $250 MILLION IN ADDITIONAL FIRST LIEN TERM LOAN AND CONCURRENT EXTINGUISHMENT OF ALL OUTSTANDING SECOND LIEN NOTES Exhibit 99.1 OPTION CARE HEALTH ANNOUNCES ISSUANCE OF $250 MILLION IN ADDITIONAL FIRST LIEN TERM LOAN AND CONCURRENT EXTINGUISHMENT OF ALL OUTSTANDING SECOND LIEN NOTES BANNOCKBURN, Ill., January 21, 2021 - Option Care Health Inc. (NASDAQ: OPCH)(“Option Care Health” or the Company”), the nation’s largest independent home and alternate site infusion services provider, announced today that it has su
December 29, 2020	SC 13D/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A (Amendment No. 4)* Under the Securities Exchange Act of 1934 Option Care Health, Inc. (Name of issuer) Common Stock, $0.0001 par value (Title of Class of Securitie UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A (Amendment No. 4)* Under the Securities Exchange Act of 1934 Option Care Health, Inc. (Name of issuer) Common Stock, $0.0001 par value (Title of Class of Securities) 68404L 102 (CUSIP number) Joshua Korff, P.C. Ross Leff, P.C. Kirkland & Ellis LLP 601 Lexington Avenue New York, New York 10022 (212) 446-4800 (Nam
December 16, 2020	SC 13D/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A (Amendment No. 3)* Under the Securities Exchange Act of 1934 Option Care Health, Inc. (Name of issuer) Common Stock, $0.0001 par value (Title of Class of Securitie UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A (Amendment No. 3)* Under the Securities Exchange Act of 1934 Option Care Health, Inc. (Name of issuer) Common Stock, $0.0001 par value (Title of Class of Securities) 68404L 102 (CUSIP number) Joshua Korff, P.C. Ross Leff, P.C. Kirkland & Ellis LLP 601 Lexington Avenue New York, New York 10022 (212) 446-4800 (Nam
December 14, 2020	424B5	10,000,000 Shares Common Stock TABLE OF CONTENTS Filed Pursuant to Rule 424(b)(5) Registration No. 333-239504 PROSPECTUS SUPPLEMENT (to Prospectus dated July 8, 2020) 10,000,000 Shares Common Stock The selling stockholder identified in this prospectus supplement is offering 10,000,000 shares of our common stock. We will not receive any of the proceeds from the shares of common stock sold by the selling stockholder. Our common
December 14, 2020	EX-1.1	Underwriting Agreement, dated as of December 10, 2020, by and among Option Care Health, Inc., HC Group Holdings I, LLC and Goldman Sachs & Co. LLC. Exhibit 1.1 Execution Version Option Care Health, Inc. 10,000,000 Shares of Common Stock, par value $0.0001 per share Underwriting Agreement December 10, 2020 Goldman Sachs & Co. LLC 200 West Street New York, NY 10282 Ladies and Gentlemen: HC Group Holdings I, LLC (the “Selling Stockholder”), a stockholder of Option Care Health, Inc., a Delaware corporation (the “Company”), proposes to sell to the
December 14, 2020	8-K	Other Events, Financial Statements and Exhibits - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) December 10, 2020 OPTION CARE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-11993 05-0489664 (State or other jurisdiction of Commission File Number)
November 3, 2020	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 3, 2020 OPTION CARE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-11993 05-0489664 (State or other jurisdiction of incorporation) (Commissio
November 3, 2020	10-Q	Quarterly Report - 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-11993 OPTIO
November 3, 2020	EX-99.1	OPTION CARE HEALTH ANNOUNCES FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2020 Exhibit 99.1 OPTION CARE HEALTH ANNOUNCES FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2020 BANNOCKBURN, IL., November 3, 2020 - Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today financial results for the third quarter ended September 30, 2020. Given
October 6, 2020	EX-10.1	First Amendment to ABL Credit Agreement, dated as of October 5, 2020, among Option Care Health, Inc. (f/k/a BioScrip, Inc.), each Guarantor party hereto, each lender party hereto and Bank of America, N.A., as administrative agent (incorporated by reference to Exhibit 10.1 of the Company's Current Report on Form 8-K filed on October 6, 2020). a101firstxamendmentxtox Exhibit 10.1 Execution Version FIRST AMENDMENT TO ABL CREDIT AGREEMENT This FIRST AMENDMENT TO ABL CREDIT AGREEMENT, dated as of October 5, 2020 (this “Amendment”), among Option Care Health, Inc. (f/k/a BioScrip, Inc.), a Delaware corporation (the “Parent Borrower” and a “Borrower”), each Guarantor party hereto, each Lender party hereto and Bank of America, N.A., as adminis
October 6, 2020	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) October 6, 2020 OPTION CARE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-11993 05-0489664 (State or other jurisdiction of incorporation) (Commission
August 20, 2020	SC 13D/A	OPCH / Option Care Health, Inc. / MADISON DEARBORN PARTNERS LLC - SC 13D/A Activist Investment CUSIP 68 404L 102 SCHEDULE 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13D/A (Amendment No.
August 4, 2020	EX-99.1	OPTION CARE HEALTH ANNOUNCES FINANCIAL RESULTS FOR THE SECOND QUARTER Exhibit 99.1 OPTION CARE HEALTH ANNOUNCES FINANCIAL RESULTS FOR THE SECOND QUARTER BANNOCKBURN, IL., August 4, 2020 - Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today financial results for the second quarter ended June 30, 2020. Given the merger between HC Group H
August 4, 2020	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 4, 2020 OPTION CARE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-11993 05-0489664 (State or other jurisdiction of incorporation) (Commission
August 4, 2020	10-Q	Quarterly Report - 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-11993 OPTION CAR
July 27, 2020	SC 13D/A	OPCH / Option Care Health, Inc. / Madison Dearborn Partners LLC - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A (Amendment No. 1)* Under the Securities Exchange Act of 1934 Option Care Health, Inc. (Name of issuer) Common Stock, $0.0001 par value (Title of Class of Securities) 68404L 102 (CUSIP number) Joshua Korff, P.C. Ross Leff, P.C. Kirkland & Ellis LLP 601 Lexington Avenue New York, New York 10022 (212) 446-4800 (Nam
July 24, 2020	EX-1.1	Underwriting Agreement, dated as of July 21, 2020, by and among Option Care Health, Inc., HC Group Holdings I, LLC and BofA Securities, Inc., as the representative of the underwriters named in Schedule 1 hereto. Exhibit 1.1 Execution Version Option Care Health, Inc. 18,000,000 Shares of Common Stock, par value $0.0001 per share Underwriting Agreement July 21, 2020 BofA Securities, Inc. One Bryant Park New York, New York 10036 Ladies and Gentlemen: Option Care Health, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the underwriters set forth on Schedule 1 hereto (the “Underwrite
July 24, 2020	8-K	Other Events, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 21, 2020 OPTION CARE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-11993 Commission File Number)
July 23, 2020	424B5	18,000,000 Shares Common Stock Use these links to rapidly review the document TABLE OF CONTENTS Table of Contents Table of Contents Filed Pursuant to Rule 424(b)(5) Registration No.
July 20, 2020	EX-99.1	OPTION CARE HEALTH ANNOUNCES PRELIMINARY FINANCIAL RESULTS FOR THE SECOND QUARTER AND SCHEDULES SECOND QUARTER EARNINGS CALL Exhibit 99.1 OPTION CARE HEALTH ANNOUNCES PRELIMINARY FINANCIAL RESULTS FOR THE SECOND QUARTER AND SCHEDULES SECOND QUARTER EARNINGS CALL BANNOCKBURN, IL., July 20, 2020 - Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today preliminary financial results for the secon
July 20, 2020	8-K	Results of Operations and Financial Condition, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 20, 2020 OPTION CARE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-11993 (Commission File Number)
July 20, 2020	424B5	Subject to Completion Preliminary Prospectus Supplement dated July 20, 2020 Use these links to rapidly review the document TABLE OF CONTENTS Table of Contents Table of Contents Filed Pursuant to Rule 424(b)(5) Registration No.
July 6, 2020	CORRESP	- Option Care Health, Inc. 3000 Lakeside Drive, Suite 300N Bannockburn, Illinois 60015 July 6, 2020 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Option Care Health, Inc. Registration Statement on Form S-3 Filing Date June 26, 2020 File No. 333-239504 REQUEST FOR ACCELERATION OF EFFECTIVENESS Pursuant to Rule 461 under the
June 26, 2020	S-3	Form S-3 (File No. 333-239504) that we initially filed with the Securities and Exchange Commission (SEC) on June 26, 2020 Table of Contents As filed with the Securities and Exchange Commission on June 26, 2020 No.
June 26, 2020	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) June 26, 2020 OPTION CARE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-11993 05-0489664 (State or other jurisdiction of incorporation) (Commission F
June 26, 2020	EX-99.1	UNAUDITED PRO FORMA COMBINED FINANCIAL STATEMENTS Exhibit 99.1 UNAUDITED PRO FORMA COMBINED FINANCIAL STATEMENTS On March 14, 2019, HC Group Holdings I, LLC (“HC I”) and HC Group Holdings II, Inc. (“HC II”) entered into a definitive agreement (the “Merger Agreement”) to merge with and into a wholly-owned subsidiary of BioScrip, Inc. (“BioScrip”), a national provider of infusion and home care management solutions, along with certain other subsidia
May 28, 2020	8-K	Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 22, 2020 OPTION CARE HEALTH, INC. (Exact name of registrant specified in its charter) Delaware 001-11993 05-0489664 (State or Other Jurisdiction (Commission (I.R.S. Employer Of In
May 7, 2020	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 7, 2020 OPTION CARE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-11993 05-0489664 (State or other jurisdiction of incorporation) (Commission Fil
May 7, 2020	10-Q	Quarterly Report - 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-11993 OPTION CA
May 7, 2020	EX-99.1	OPTION CARE HEALTH ANNOUNCES FINANCIAL RESULTS FOR THE FIRST QUARTER AND PROVIDES AN UPDATE ON THE IMPACT OF COVID-19 PANDEMIC Exhibit 99.1 OPTION CARE HEALTH ANNOUNCES FINANCIAL RESULTS FOR THE FIRST QUARTER AND PROVIDES AN UPDATE ON THE IMPACT OF COVID-19 PANDEMIC BANNOCKBURN, IL., May 7, 2020 - Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today financial results for the first quarter end
April 10, 2020	DEF 14A	portions of our Definitive Proxy Statement on Schedule 14A, filed with the SEC on April 10, 2020 TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e
April 10, 2020	DEFA14A	OPCH / Option Care Health, Inc. DEFA14A - - DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Defin
March 5, 2020	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) March 5, 2020 OPTION CARE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-11993 05-0489664 (State or other jurisdiction of incorporation) (Commission F

MX:OPCH
IT:1OPCH	€ 24.60
DE:MM6A	€ 24.40

OPCH / Option Care Health, Inc. - Pengajuan SECLaporan Tahunan, Pernyataan Proksi

Mga Batayang Estadistika

SEC Filings

SEC Filings (Chronological Order)

Other Listings